前列腺增生合并前列腺炎的临床研究

Clinical Study of Benign Prostatic Hyperplasia Combined with Chronic Prostatitis

目的:探讨良性前列腺增生(BPH)合并慢性前列腺炎(CP)的临床特点。方法:回顾性分析82例BPH患者的临床资料,根据病理结果将其分为单纯BPH组(29例)与合并CP组(53例),对比两组患者年龄、病程、前列腺体积、PSA、IPSS等的差异。结果:BPH合并CP发生率为64.6%(53/82),Ⅲ度BPH患者合并CP发生率显著高于Ⅰ度、Ⅱ度患者(均P<0.01);与单纯BPH组相比BPH合并CP组患者年龄、病程均显著较高(均P<0.05);前列腺体积显著增大(P<0.01);血PSA及IPSS评分均显著增高(均P<0.01)。结论:与单纯BPH患者相比,合并CP患者多具有年龄较大、病程较长、前列腺体积较大、血PSA及IPSS评分均较高等特征。了解上述特点,对于该病的积极治疗具有重要的指导意义。

Objective：To study the clinical feature of benign prostatic hyperplasia（BPH） combined with chronic prostatitis（CP）.Methods：82 patients with BPH were divided into BPH group（29 cases） and BPH/CP group （BPH combined with CP,53 cases）,patients age,course of disease,prostate volume,PSA,and IPSS were contrasted between the two groups.Results：The rate of BPH combined with CP was 64.6%（53/82）,and was significantly higher in the patients with Ⅲ BPH thanⅠ,Ⅱ degrees（P0.01）.Compared with the BPH group,patients age,course of disease was significantly older or longer,prostate volume was significantly biger,PSA and IPSS were significantly higher in the BPH/CP group（P0.05 or P0.01）.Conclusion：Compared with pure BPH patients,patients with BPH combined with CP have older age,longer disease course,biger prostate volume,higher PAS and IPSS,understanding these characteristics has important guiding significance for active treatment of this disease.